The rating affirmation is based on a number of factors, including Dartmouth-Hitchcock’s strong market presence, weakened liquidity and poor financial performance in fiscal year 2016.
The outlook is stable.
More articles on healthcare finance:
Healthcare RCM M&A activity expected to rise in 2017: 9 things to know
10 largest gifts from individuals to healthcare organizations in 2016
HCCI: Providers’ rising prices main driver behind 4.6% spending growth
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
